Evidence map›Paper›PMID 27303746›Full record

ArticlemSphere

Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome.

Angela C Poole, Lauren Pischel, Catherine Ley, Gina Suh, Julia K Goodrich, Thomas D Haggerty, Ruth E Ley, Julie Parsonnet

Abstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. A Pilot Study of the Gut Microbiota in Spine Fusion Surgery Patients.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Angela C PooleDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, New York, USA; Department of Microbiology, Cornell University, Ithaca, New York, USA.
Lauren PischelDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Catherine LeyDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Gina SuhDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Julia K GoodrichDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, New York, USA.
Thomas D HaggertyDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Ruth E LeyDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, New York, USA; Department of Microbiology, Cornell University, Ithaca, New York, USA.
Julie ParsonnetDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
Childhood infection and prevention of obesityR01HD063142 · NICHD · STANFORD UNIVERSITY · PI PARSONNET, JULIE · 2009 to 2013
$3.7M
Household Triclosan and Triclocarban Use and the Developing Infant MicrobiomeR21ES023371 · NIEHS · STANFORD UNIVERSITY · PI PARSONNET, JULIE · 2014 to 2016
$974k
NICHD NIH HHS R01 HD063142NIEHS NIH HHS R21 ES023371NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Commonly prescribed antibiotics are known to alter human microbiota. We hypothesized that triclosan and triclocarban, components of many household and personal care products (HPCPs), may alter the oral and gut microbiota, with potential consequences for metabolic function and weight. In a double-blind, randomized, crossover study, participants were given triclosan- and triclocarban (TCS)-containing or non-triclosan/triclocarban (nTCS)-containing HPCPs for 4 months and then switched to the other products for an additional 4 months. Blood, stool, gingival plaque, and urine samples and weight data were obtained at baseline and at regular intervals throughout the study period. Blood samples were analyzed for metabolic and endocrine markers and urine samples for triclosan. The microbiome in stool and oral samples was then analyzed. Although there was a significant difference in the amount of triclosan in the urine between the TCS and nTCS phases, no differences were found in microbiome composition, metabolic or endocrine markers, or weight. Though this study was limited by the small sample size and imprecise administration of HPCPs, triclosan at physiologic levels from exposure to HPCPs does not appear to have a significant or important impact on human oral or gut microbiome structure or on a panel of metabolic markers. IMPORTANCE Triclosan and triclocarban are commonly used commercial microbicides found in toothpastes and soaps. It is unknown what effects these chemicals have on the human microbiome or on endocrine function. From this randomized crossover study, it appears that routine personal care use of triclosan and triclocarban neither exerts a major influence on microbial communities in the gut and mouth nor alters markers of endocrine function in humans.

Indexed as

microbicidemicrobiomerandomized double-blind crossover studytriclosan

Identifiers

PMID27303746
PMCPMC4888890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.